Evidence map›Paper›PMID 34146476›Full record

Observational studyThe Lancet. Infectious diseases2021

Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study.

Chiara Andolina, John C Rek, Jessica Briggs, Joseph Okoth, Alex Musiime, Jordache Ramjith, Noam Teyssier, Melissa Conrad, Joaniter I Nankabirwa, Kjerstin Lanke and 11 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in The Lancet. Infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 4 pooled it
34.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 4 syntheses or guidelines pooled it, 225 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. High-AltitudeOpen forum infectious diseases · 2026
    Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 4 countries.

Chiara AndolinaDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands.
John C RekInfectious Diseases Research Collaboration, Kampala, Uganda.
Jessica BriggsDepartment of Medicine, University of California, San Francisco, CA, USA.
Joseph OkothInfectious Diseases Research Collaboration, Kampala, Uganda.
Alex MusiimeInfectious Diseases Research Collaboration, Kampala, Uganda.
Jordache RamjithDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, Netherlands.
Noam TeyssierDepartment of Medicine, University of California, San Francisco, CA, USA.
Melissa ConradDepartment of Medicine, University of California, San Francisco, CA, USA.
Joaniter I NankabirwaInfectious Diseases Research Collaboration, Kampala, Uganda; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Kjerstin LankeDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands.
Isabel Rodriguez-BarraquerDepartment of Medicine, University of California, San Francisco, CA, USA.
Lisette Meerstein-KesselDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands.
Emmanuel ArinaitweInfectious Diseases Research Collaboration, Kampala, Uganda.
Peter OlwochInfectious Diseases Research Collaboration, Kampala, Uganda.
Philip J RosenthalDepartment of Medicine, University of California, San Francisco, CA, USA.
Moses R KamyaInfectious Diseases Research Collaboration, Kampala, Uganda; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Grant DorseyDepartment of Medicine, University of California, San Francisco, CA, USA.
Bryan GreenhouseDepartment of Medicine, University of California, San Francisco, CA, USA.
Chris DrakeleyDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
Sarah G StaedkeDepartment of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
Teun BousemaDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands. Electronic address: teun.bousema@radboudumc.nl.
University of California, San Francisco · USInfectious Diseases Research Collaboration · UGRadboud University Medical Center · NLLondon School of Hygiene & Tropical Medicine · GBMakerere University · UGRadboud University Nijmegen · NL

Funding

Transmission ProjectU19AI089674 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joaniter Immaculate Nankabirwa · 2010 to 2026
$29.3M
Resistance of Malaria Parasites to Artemisinin-Based TherapiesR01AI075045 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSENTHAL, PHILIP JON · 2009 to 2024
$8.4M
BIOLOGY OF INFECTIOUS DISEASES TRAINING PROGRAMT32AI007641 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW G DORSEY · 2000 to 2026
$6.9M
Mentoring translational scientists in international infectious disease researchK24AI144048 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bryan R Greenhouse · 2019 to 2026
$1.6M
The impact of antimalarials and insecticide resistance on malaria transmission in UgandaK01TW010868 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CONRAD, MELISSA D · 2018 to 2022
$706k
Resistance of Malaria Parasites to Artemisinin-Based Combination TherapiesR56AI075045 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSENTHAL, PHILIP JON · 2008 to 2008
$618k
FIC NIH HHS K01 TW010868NIAID NIH HHS K24 AI144048NIAID NIH HHS R01 AI075045NIAID NIH HHS R56 AI075045NIAID NIH HHS U19 AI089674
6 · The paper itself

Abstract

backgroundSymptomatic malaria cases reflect only a small proportion of all Plasmodium spp infections. Many infected individuals are asymptomatic, and persistent asymptomatic Plasmodium falciparum infections are common in endemic settings. We aimed to quantify the contribution of symptomatic and asymptomatic infections to P falciparum transmission in Tororo, Uganda.

methodsWe did a longitudinal, observational cohort study in Tororo district, Uganda. We recruited participants of all ages from randomly selected households within this district. Participants were eligible if the selected household had no more than nine permanent residents and at least two members younger than 10 years, and the household was their primary residence, and they agreed to come to the study clinic for any fever episode and avoid antimalarial medications outside the study. Participants were followed-up by continuous passive surveillance for the incidence of symptomatic infections; routine assessments (ie, standardised clinical evaluation and blood samples) were done at baseline and at routine visits every 4 weeks for 2 years. P falciparum parasite density, gametocyte density, and genetic composition were determined molecularly using quantitative PCR (qPCR), quantitative reverse transcriptase PCR (qRT-PCR), and amplicon deep sequencing, respectively. Membrane feeding assays were also done to assess infectivity to mosquitoes. The contribution of different populations to the infectious reservoir was estimated for symptomatic infections, asymptomatic but microscopically detected infections, and asymptomatic but qPCR-detected infections; and for age groups younger than 5 years, 5-15 years, and 16 years or older.

findingsBetween Oct 4, 2017, and Oct 31, 2019, 531 individuals were enrolled from 80 randomly selected households and were followed-up for 2 years. At baseline, P falciparum was detected in 28 (5·3%) of 531 participants by microscopy and an additional 64 (12·1%) by qPCR and declined thereafter. In 538 mosquito feeding experiments on 107 individuals, 446 (1·2%) of 37 404 mosquitoes became infected, with mosquito infection rates being strongly associated with gametocyte densities (β=2·11, 95% CI 1·62-2·67; p<0·0001). Considering both transmissibility of infections and their relative frequency, the estimated human infectious reservoir consisted primarily of asymptomatic microscopy-detected infections (83·8%), followed by asymptomatic submicroscopic infections (15·6%), and symptomatic infections (0·6%). Children aged 5-15 years accounted for more than half of the infectious reservoir (58·7%); individuals younger than 5 years (25·8%) and those 16 years or older (15·6%) contributed less. Samples from four children contribued to 279 (62·6%) of 446 infected mosquitoes after multiple mosquito-feeding assays.

interpretationIndividuals with asymptomatic infections were important drivers of malaria transmission. School-aged children contributed to more than half of all mosquito infections, with a small minority of asymptomatic children being highly infectious. Demographically targeted interventions, aimed at school-aged children, could further reduce transmission in areas under effective vector control.

fundingUS National Institutes of Health, Bill & Melinda Gates Foundation, and the European Research Council.

Indexed as

AdolescentAnimalsAnophelesAntimalarialsArtemether, Lumefantrine Drug CombinationChildChild, PreschoolCohort StudiesFemaleHumansLongitudinal StudiesMalaria, FalciparumMalePlasmodium falciparumUgandaAntimalarialsArtemether, Lumefantrine Drug Combination

Identifiers

PMID34146476
PMCPMC8554388
OpenAlexW3173063591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.